ArticleBlood advances2020

Genomic context and TP53 allele frequency define clinical outcomes in TP53-mutated myelodysplastic syndromes.

Guillermo Montalban-Bravo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.